Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Transplant Lymphoproliferative Disorder”

675 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 675 results

Testing effectiveness (Phase 2)Study completedNCT01936532
What this trial is testing

Safety and Efficacy Study of a Triplet Combination of MLN9708, Lenalidomide and Dexamethasone in the Initial Management of Multiple Myeloma (IFM2013-06)

Who this might be right for
Newly Diagnosed Multiple Myeloma
Nantes University Hospital 42
Large-scale testing (Phase 3)Looking for participantsNCT05827016
What this trial is testing

Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Bristol-Myers Squibb 1,216
Testing effectiveness (Phase 2)Study completedNCT01718743
What this trial is testing

Ixazomib Citrate and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Hematopoietic Cell Transplantation RecipientPlasma Cell Myeloma
M.D. Anderson Cancer Center 64
Early research (Phase 1)Study completedNCT01362452
What this trial is testing

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 5
Not applicableStudy completedNCT06119633
What this trial is testing

Implant-based Breast Reconstruction and Mastectomy With Fat Grafting After Breast Conserving Surgery and Radiotherapy

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 163
Testing effectiveness (Phase 2)WithdrawnNCT05966233
What this trial is testing

R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma RefractoryDiffuse Large B-cell Lymphoma Recurrent
Fondazione Italiana Linfomi - ETS
Testing effectiveness (Phase 2)Study completedNCT01323920
What this trial is testing

Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 35
Testing effectiveness (Phase 2)Ended earlyNCT02353468
What this trial is testing

Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant

Who this might be right for
Refractory Plasma Cell Myeloma
University of Colorado, Denver 3
Testing effectiveness (Phase 2)Study completedNCT00616720
What this trial is testing

Interferon-gamma or Aldesleukin and Vaccine Therapy in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 15
Testing effectiveness (Phase 2)Looking for participantsNCT06904482
What this trial is testing

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Who this might be right for
aGVHDAcute Myelogenous LeukemiaAcute Lymphocytic Leukemia+1 more
Case Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT02210065
What this trial is testing

Autologous Cytomegalovirus (CMV)-Specific Cytotoxic T Cells for Cytomegalovirus (CMV) Reactivation

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT02424968
What this trial is testing

CD8+ Memory T-Cells as Consolidative Therapy After Donor Non-myeloablative Hematopoietic Cell Transplant in Treating Patients With Leukemia or Lymphoma

Who this might be right for
Acute Myeloid LeukemiaB-Cell Non-Hodgkin LymphomaChronic Lymphocytic Leukemia+4 more
Robert Lowsky 18
Large-scale testing (Phase 3)UnknownNCT00003924
What this trial is testing

Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Lymphoma Study Association 360
Testing effectiveness (Phase 2)Ended earlyNCT00946023
What this trial is testing

Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab

Who this might be right for
LymphomaB-cell LymphomaNon Hodgkin Lymphoma+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 135
Not applicableStudy completedNCT02716103
What this trial is testing

Assessment of Minimal Residual Disease (MRD) After Antineoplastic Treatment in Patients With AL Amyloidosis

Who this might be right for
Amyloidosis
Boston Medical Center 45
Testing effectiveness (Phase 2)Study completedNCT01575860
What this trial is testing

Maintenance Lenalidomide in Lymphoma

Who this might be right for
Lymphoma
Abramson Cancer Center at Penn Medicine 8
Testing effectiveness (Phase 2)Study completedNCT00186628
What this trial is testing

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

Who this might be right for
Leukemia, Mast-CellMantle-cell Lymphoma
Stanford University 36
Testing effectiveness (Phase 2)Looking for participantsNCT05393804
What this trial is testing

Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)Study completedNCT01177371
What this trial is testing

High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+70 more
Case Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Ended earlyNCT02906332
What this trial is testing

Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
Hackensack Meridian Health 12
Load More Results